Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026)
Nuwellis (NUWE) posted Total Non-Current Liabilities of $3.9 million for Q1 2026, up 26.82% on a QoQ basis from $3.1 million in Q4 2025, and up 31.09% year-over-year from $3.0 million in Q1 2025.
Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
Nuwellis' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 31.09% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 31.09% YoY) and the FY2025 annual result came in at $3.1 million, up 8.13% from the prior year.
- Total Non-Current Liabilities was $3.9 million for Q1 2026 at Nuwellis, up from $3.1 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $8.2 million in Q2 2025 and bottomed at $2.9 million in Q4 2024.
- A 5-year average of $4.2 million and a median of $4.3 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Peak annual rise in Total Non-Current Liabilities reached 83.51% in 2025, while the deepest fall reached 37.68% in 2025.
- Nuwellis' Total Non-Current Liabilities stood at $5.4 million in 2022, then tumbled by 31.79% to $3.7 million in 2023, then declined by 22.87% to $2.9 million in 2024, then increased by 8.13% to $3.1 million in 2025, then grew by 26.82% to $3.9 million in 2026.
- Business Quant data shows NUWE's Total Non-Current Liabilities at $3.9 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 4.47 Mn |
| Sep 30, 2021 | 3.83 Mn |
| Dec 31, 2020 | 3.69 Mn |